Mild cognitive impairment in the general population: occurrence and progression to Alzheimer disease

Katie Palmer1, Lars Bäckman, Bengt Winblad

  • 1Aging Research Center, Karolinska Institutet, and Stockholm Gerontology Research Center, Stockholm, Sweden. katie.palmer@ki.se

Abstract

Insights

Modified criteria for mild cognitive impairment (MCI) identify more cases and predict Alzheimer's disease (AD) risk. MCI-multidomains showed the highest progression to AD, highlighting the need for refined diagnostic approaches.

Area of Science:

  • Neurology
  • Gerontology
  • Cognitive Science

Background:

  • Mild cognitive impairment (MCI) subtypes require better population-level detection.
  • Current MCI criteria may miss individuals at high risk for Alzheimer's disease (AD).
  • Understanding MCI subtype progression is crucial for early AD intervention.

Purpose of the Study:

  • To detect the prevalence of three MCI subtypes in the general population.
  • To identify cognitive impairment cases missed by current MCI criteria.
  • To determine the predictive value of MCI subtypes for future Alzheimer's disease.

Main Methods:

  • A three-year prospective, population-based study (Kungsholmen Project) in Sweden.
  • Inclusion of 379 non-demented adults aged 75-95.
  • Application of standard and modified MCI criteria, with modified definitions removing the normal general cognition requirement and adding a category for global cognitive deficits without MCI.

Main Results:

  • Prevalence rates per 100 non-demented individuals: MCI-amnestic (2.1%), MCI-multidomains (1.8%), MCI-single-nonmemory (7.2%).
  • Modified MCI definitions nearly doubled the occurrence of MCI-amnestic and MCI-multidomains.
  • MCI-multidomains demonstrated the highest progression to AD (HR: 23.6), followed by modified MCI-amnestic (HR: 17.9). Individuals with global deficits but no MCI also showed a ninefold increased risk (HR: 9.1).

Conclusions:

  • MCI-multidomains and MCI-amnestic subtypes show significant progression to Alzheimer's disease.
  • Modified diagnostic criteria are essential for capturing individuals at high risk, including those with global cognitive deficits but not meeting standard MCI criteria.
  • Current standard MCI criteria may underestimate the population at risk for AD.

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.